Update on Stevens Johnson Syndrome

100.9K

views

69

authors

18

articles

Update on Stevens Johnson Syndrome

100.9K

views

69

authors

18

articles

Editorial

22 December 2021

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Shigeru Kinoshita

and

Mayumi Ueta

2,327 views

1 citations

Editors

3

Singapore National Eye Center

Kyoto Prefectural University of Medicine

Shigeru Kinoshita

Kyoto Prefectural University of Medicine

Impact

About

Stevens-Johnson Syndrome (SJS) is a severely debilitating disease of the skin and mucosal system. It is a multi-system disorder and forms part of the spectrum of disease with toxic epidermal necrolysis (TEN). Acute and chronic management of the SJS patient can be challenging for both the internist, dermatologist, and ophthalmologist. Hence a multidisciplinary team will often have to look after the patient. Much has been learned about underlying genetic risk factors and triggers for the disease. Acute and chronic management of patients with SJS requires extensive reconstruction of both the mucosal surface and skin.

The topic will highlight new therapies and advances in the acute and chronic management of the SJS patient with severe ocular complications. We would like to highlight how early active intervention will improve long-term outcomes, and also visual rehabilitation in these patients. We would also like to cover new advances in biologic therapy, ocular surface treatment in the chronic stage, and gain a better understanding of the ocular microbiome and genetic predisposition in these patients.

We welcome articles related to:

• Advances in the management of ocular surface disease in SJS patients
• Microbiome in SJS patients
• New therapies in improving ocular/skin outcomes in SJS
• Systemic management in SJS patients
• Genomics of SJS

Stevens-Johnson Syndrome (SJS) is a severely debilitating disease of the skin and mucosal system. It is a multi-system disorder and forms part of the spectrum of disease with toxic epidermal necrolysis (TEN). Acute and chronic management of the SJS patient can be challenging for both the internist, dermatologist, and ophthalmologist. Hence a multidisciplinary team will often have to look after the patient. Much has been learned about underlying genetic risk factors and triggers for the disease. Acute and chronic management of patients with SJS requires extensive reconstruction of both the mucosal surface and skin.

The topic will highlight new therapies and advances in the acute and chronic management of the SJS patient with severe ocular complications. We would like to highlight how early active intervention will improve long-term outcomes, and also visual rehabilitation in these patients. We would also like to cover new advances in biologic therapy, ocular surface treatment in the chronic stage, and gain a better understanding of the ocular microbiome and genetic predisposition in these patients.

We welcome articles related to:

• Advances in the management of ocular surface disease in SJS patients
• Microbiome in SJS patients
• New therapies in improving ocular/skin outcomes in SJS
• Systemic management in SJS patients
• Genomics of SJS

Download ebook

Share

Editors

Singapore National Eye Center

Kyoto Prefectural University of Medicine

Shigeru Kinoshita

Kyoto Prefectural University of Medicine

Impact

100,889 Total views

77,923 Article views

21,223 Article downloads

1,743 Topic views

Published In

Journal Thumbnail

Frontiers in Medicine

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Suggest a topic